cdmo.directory
← Compare landing

AmbioPharm vs Richter BioLogics

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ambiopharm/richterbiologics

CategoryAmbioPharmRichter BioLogics
Listed sitecdmocdmo
SummaryFDA-inspected peptide API manufacturer offering GMP custom synthesis, process development, analytical method validation, and vaccine peptide manufacturing from preclinical through commercial scale.Germany-based CDMO specializing in GMP-compliant microbial production of recombinant proteins, peptides, plasmid DNA, and bacterial vaccines with bioreactor capacity up to 1,500 litres and regulatory clearance from FDA, EMA, ANVISA, PMDA, and MFDS.
Services
  • Peptide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Vaccine Manufacturing
  • API Synthesis & Manufacturing
  • Process Development
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Quality Control Testing
  • Recombinant Protein Manufacturing
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Microbial Fermentation
Modalities
  • Peptide
  • Vaccine
  • Biologics (Other)
  • Vaccine
  • Peptide
IndicationsData not yet provided.Data not yet provided.
Locations
  • North Augusta, North Augusta, South Carolina, United States
  • Headquarters / Development & Manufacturing, Germany, Germany
CertificationsData not yet provided.
  • FDA · Identifier: FDA inspection - zero findings
  • EMA · Identifier: EMA verified
  • ANVISA · Identifier: ANVISA verified
  • PMDA · Identifier: PMDA verified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.